Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NTLA

Intellia Therapeutics Inc

Jun 08 • 12:53PM ET

13.48

-0.06 -0.41 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BEAM CRSP EDIT VIR BMRN IONS ALNY INCY VRTX SNDX

| Held by: ARKK VTI XBI VB ARKG IWM VBK VXF IBB IWN

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.53	Insider Own	3.32%	Shs Outstand	139.72M	Perf Week	-1.78%
Market Cap	1.88B	Forward P/E	-	EPS next Y	-1.88	Insider Trans	-0.51%	Shs Float	132.47M	Perf Month	-1.64%
Enterprise Value	1.59B	PEG	-	EPS next Q	-0.81	Inst Own	76.22%	Short Float	39.14%	Perf Quarter	-2.92%
Income	-394.60M	P/S	28.51	EPS this Y	15.72%	Inst Trans	4.78%	Short Ratio	9.38	Perf Half Y	38.45%
Sales	66.09M	P/B	2.62	EPS next Y	41.30%	ROA	-45.23%	Short Interest	51.85M	Perf YTD	50.00%
Book/sh	5.16	P/C	5.01	EPS next 5Y	43.91%	ROE	-56.34%	52W High	28.25 -52.27%	Perf Year	66.69%
Cash/sh	2.69	P/FCF	-	EPS past 3/5Y	14.82% -9.70%	ROIC	-57.83%	52W Low	7.75 74.00%	Perf 3Y	-68.90%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.09% 3.13%	Gross Margin	76.32%	Volatility	9.65% 7.98%	Perf 5Y	-82.93%
Dividend TTM	-	EV/Sales	24.04	EPS Y/Y TTM	32.42%	Oper. Margin	-636.56%	ATR (14)	1.09	Perf 10Y	-52.43%
Dividend Ex-Date	-	Quick Ratio	6.10	Sales Y/Y TTM	45.04%	Profit Margin	-597.04%	RSI (14)	50.03	Recom	2.23
Dividend Gr. 3/5Y	- -	Current Ratio	6.10	EPS Q/Q	26.48%	SMA20	1.10%	Beta	1.80	Target Price	26.61
Payout	-	Debt/Eq	0.13	Sales Q/Q	-9.50%	SMA50	-1.13%	Rel Volume	0.55	Prev Close	13.54
Employees	377	LT Debt/Eq	0.10	Earnings	May 11 BMO	SMA200	0.91%	Avg Volume	5.53M	Price	13.48
IPO	May 06, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.06% 8.99%	Trades		Volume	1,643,013	Change	-0.41%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)